miRNA Details
miRNA General Information | |||||
---|---|---|---|---|---|
miRNA Mature ID | hsa-miR-26a-5p | ||||
miRNA Stemloop AC | MI0000083 | MI0000750 | ||||
miRNA Stemloop ID | hsa-mir-26a-1 | hsa-mir-26a-2 | ||||
Sequence | uucaaguaauccaggauaggcu | ||||
TTD Target(s) Regulated by This miRNA | Enhancer of zeste homolog 2 (EZH2) | Successful Target | Target Info | [1] | |
TGF-beta receptor type II (TGFBR2) | Clinical trial Target | Target Info | [2] | ||
Protein(s) Regulated by This miRNA | ADP-ribosylation factor-like protein 4C | Regulated Protein | [3] | ||
Alpha-(1,6)-fucosyltransferase | Regulated Protein | [4] | |||
Alpha-methylacyl-CoA racemase | Regulated Protein | [5] | |||
BAG family molecular chaperone regulator 4 | Regulated Protein | [6] | |||
Cell division control protein 6 homolog | Regulated Protein | [1] | |||
Chromodomain-helicase-DNA-binding protein 1 | Regulated Protein | [8] | |||
Cyclin-dependent kinases regulatory subunit 2 | Regulated Protein | [9] | |||
Cytoplasmic polyadenylation element-binding protein 2 | Regulated Protein | [10] | |||
Cytoplasmic polyadenylation element-binding protein 3 | Regulated Protein | [10] | |||
Cytoplasmic polyadenylation element-binding protein 4 | Regulated Protein | [10] | |||
Dual specificity protein phosphatase 4 | Regulated Protein | [11] | |||
Fibroblast growth factor 9 | Regulated Protein | [12] | |||
G/T mismatch-specific thymine DNA glycosylase | Regulated Protein | [13] | |||
G1/S-specific cyclin-D2 | Regulated Protein | [14] | |||
Ganglioside-induced differentiation-associated protein 1 | Regulated Protein | [15] | |||
La-related protein 1 | Regulated Protein | [16] | |||
Methylcytosine dioxygenase TET2 | Regulated Protein | [13] | |||
Mothers against decapentaplegic homolog 4 | Regulated Protein | [17] | |||
Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Regulated Protein | [18] | |||
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha | Regulated Protein | [19] | |||
Plasminogen activator inhibitor 1 RNA-binding protein | Regulated Protein | [20] | |||
Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 | Regulated Protein | [21] | |||
Protein jagged-1 | Regulated Protein | [22] | |||
Protein lin-28 homolog B | Regulated Protein | [23] | |||
RCC1 and BTB domain-containing protein 1 | Regulated Protein | [24] | |||
Retinoblastoma-associated protein | Regulated Protein | [25] | |||
STE20-related kinase adapter protein beta | Regulated Protein | [1] | |||
Terminal uridylyltransferase 4 | Regulated Protein | [23] | |||
Thioredoxin-dependent peroxide reductase, mitochondrial | Regulated Protein | [26] | |||
Transcription factor E2F7 | Regulated Protein | [27] | |||
Type 2 lactosamine alpha-2,3-sialyltransferase | Regulated Protein | [28] | |||
Zinc finger protein PLAG1 | Regulated Protein | [2] | |||
References | |||||
REF 1 | MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood. 2008 Nov 15;112(10):4202-12. | ||||
REF 2 | A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61. | ||||
REF 3 | MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7. FEBS Lett. 2012 May 21;586(10):1472-9. | ||||
REF 4 | Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs.Oncotarget. 2016 Sep 20;7(38):61199-61214. | ||||
REF 5 | Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs.BMC Cancer. 2014 Feb 11;14:82. | ||||
REF 6 | MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD).J Invest Dermatol. 2013 May;133(5):1286-93. | ||||
REF 7 | MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood. 2008 Nov 15;112(10):4202-12. | ||||
REF 8 | Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2.Breast Cancer Res. 2014 Apr 15;16(2):R40. | ||||
REF 9 | miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.PLoS One. 2013 Jul 5;8(7):e67591. | ||||
REF 10 | CPEB2, CPEB3 and CPEB4 are coordinately regulated by miRNAs recognizing conserved binding sites in paralog positions of their 3'-UTRs.Nucleic Acids Res. 2010 Nov;38(21):7698-710. | ||||
REF 11 | MiR-26a enhances autophagy to protect against ethanol-induced acute liver injury.J Mol Med (Berl). 2015 Sep;93(9):1045-55. | ||||
REF 12 | miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer.PLoS One. 2013 Aug 28;8(8):e72662. | ||||
REF 13 | MicroRNA-26a targets ten eleven translocation enzymes and is regulated during pancreatic cell differentiation.Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17892-7. | ||||
REF 14 | Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.Cell. 2009 Jun 12;137(6):1005-17. | ||||
REF 15 | A comprehensive analysis of microRNA expression during human keratinocyte differentiation in vitro and in vivo. J Invest Dermatol. 2011 Jan;131(1):20-9. | ||||
REF 16 | MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer.Int J Oncol. 2015 Aug;47(2):710-8. | ||||
REF 17 | MicroRNA-26a is a novel regulator of vascular smooth muscle cell function.J Cell Physiol. 2011 Apr;226(4):1035-43. | ||||
REF 18 | MiR-26 down-regulates TNF-/NF-B signalling and IL-6 expression by silencing HMGA1 and MALT1.Nucleic Acids Res. 2016 May 5;44(8):3772-87. | ||||
REF 19 | MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2/Akt/HIF-1 pathway in hepatocellular carcinoma.PLoS One. 2013 Oct 23;8(10):e77957. | ||||
REF 20 | Identification of human microRNA targets from isolated argonaute protein complexes.RNA Biol. 2007 Jun;4(2):76-84. | ||||
REF 21 | Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.Int J Oncol. 2016 May;48(5):1837-46. | ||||
REF 22 | MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.Oncogene. 2017 Jan 12;36(2):231-241. | ||||
REF 23 | miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasis.Oncogene. 2014 Aug 21;33(34):4296-306. | ||||
REF 24 | Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survival.Oncogenesis. 2013 May 20;2:e47. | ||||
REF 25 | Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship.Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2183-8. | ||||
REF 26 | MicroRNA-26a-5p and microRNA-23b-3p up-regulate peroxiredoxin III in acute myeloid leukemia.Leuk Lymphoma. 2015 Feb;56(2):460-71. | ||||
REF 27 | The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells.Cell Death Dis. 2012 Oct 25;3:e413. | ||||
REF 28 | Sialyltransferase ST3GAL6 mediates the effect of microRNA-26a on cell growth, migration, and invasion in hepatocellular carcinoma through the protein kinase B/mammalian target of rapamycin pathway.Cancer Sci. 2017 Feb;108(2):267-276. | ||||
REF 29 | A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.